Scarica l'app Stockscreener
1.80
8.16%
-0.16
Dopo l'orario di chiusura:
1.89
0.09
+5.00%
Precedente Chiudi:
$1.96
Aprire:
$1.96
Volume 24 ore:
3.02M
Relative Volume:
1.78
Capitalizzazione di mercato:
$411.04M
Reddito:
$8.95M
Utile/perdita netta:
$-21.49M
Rapporto P/E:
-15.00
EPS:
-0.12
Flusso di cassa netto:
$-29.24M
1 W Prestazione:
+4.05%
1M Prestazione:
+6.51%
6M Prestazione:
+266.82%
1 anno Prestazione:
+114.64%
Intervallo 1D:
$1.80
$1.97
Intervallo di 1 settimana:
$1.66
$2.09
Portata 52W:
$0.3651
$2.09
Lineage Cell Therapeutics Inc Stock (LCTX) Company Profile
Nome
Lineage Cell Therapeutics Inc
Settore
Industria
Telefono
510-871-4188
Indirizzo
2173 Salk Avenue, Suite 200, Carlsbad, CA
Confronta LCTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LCTX
Lineage Cell Therapeutics Inc
|
1.80 | 447.58M | 8.95M | -21.49M | -29.24M | -0.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lineage Cell Therapeutics Inc Stock (LCTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-20 | Iniziato | Craig Hallum | Buy |
| 2022-11-02 | Iniziato | Robert W. Baird | Outperform |
| 2022-06-14 | Iniziato | B. Riley Securities | Buy |
| 2021-08-19 | Iniziato | Noble Capital Markets | Outperform |
| 2021-03-31 | Iniziato | Cantor Fitzgerald | Overweight |
Lineage Cell Therapeutics Inc Borsa (LCTX) Ultime notizie
Is Lineage Cell Therapeutics Inc. stock a top pick in earnings season2025 Investor Takeaways & Community Consensus Trade Signals - newser.com
Can Lineage Cell Therapeutics Inc. rally from current levelsJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Lineage Cell Therapeutics Hits New 52-Week High of $1.95 - Markets Mojo
Forecasting Lineage Cell Therapeutics Inc. price range with options data2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com
Lineage Cell Therapeutics advances regenerative medicine with scalable therapies - Traders Union
Will Lineage Cell Therapeutics Inc. stock benefit from commodity pricesQuarterly Growth Report & Safe Investment Capital Preservation Plans - newser.com
Will Lineage Cell Therapeutics Inc. stock outperform international peersWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Published on: 2025-11-03 06:28:30 - newser.com
Regression analysis insights on Lineage Cell Therapeutics Inc. performanceJuly 2025 Decliners & Weekly Breakout Watchlists - newser.com
How to build a custom watchlist for Lineage Cell Therapeutics Inc.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
How institutional buying supports Lineage Cell Therapeutics Inc. stockPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Tools to assess Lineage Cell Therapeutics Inc.’s risk profile2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
How hedge fund analytics apply to Lineage Cell Therapeutics Inc. stock2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How Lineage Cell Therapeutics Inc. stock reacts to Fed tightening2025 Price Targets & Community Consensus Picks - newser.com
Is Lineage Cell Therapeutics Inc. stock a momentum leaderJuly 2025 Setups & AI Forecast Swing Trade Picks - newser.com
Is Lineage Cell Therapeutics Inc. stock undervalued historicallyMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Tools to monitor Lineage Cell Therapeutics Inc. recovery probabilityNew Guidance & Intraday High Probability Alerts - newser.com
Lineage Cell Therapeutics (LCTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is Lineage Cell Therapeutics Inc. stock cheap by valuation metrics2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
How Lineage Cell Therapeutics Inc. stock performs during market turbulence2025 Earnings Surprises & Stock Portfolio Risk Control - newser.com
Lineage Cell Therapeutics Hits New 52-Week High of $1.87 - Markets Mojo
How Lineage Cell Therapeutics Inc. stock moves on employment data2025 Momentum Check & Smart Money Movement Tracker - newser.com
Published on: 2025-11-02 02:45:07 - newser.com
Why hedge funds are buying Lineage Cell Therapeutics Inc. stockQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Published on: 2025-11-02 04:56:29 - newser.com
Lineage Cell Therapeutics Inc Azioni (LCTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):